A multinational research group has been the first to show the excellent activity of artemisinin-based treatment against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cell lines – including a specific type of lung cells. Their findings were recently published in the journal Scientific Reports.

Traditional Chinese medicine in COVID-19 - ScienceDirect

Green Artemisia Annua Plant at Rs 25/piece in Ghaziabad, artemisia annua

St. John's Nutrition

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male rats [

Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19), BMC Complementary Medicine and Therapies

Frontiers Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus

Frontiers A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review

Molecules, Free Full-Text

St. John's Nutrition

Frontiers Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro